Blood Cancer Journal - Table of Contents alert Volume 8 January 2018

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 8 (January 2018) In this issue Corrigendum Current Treatment Algorithm Article Review Article Correspondence   Sign up for e-alerts Web feed Corrigendum The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor R Wu, A Sattarzadeh, B Rutgers, A Diepstra, A van den Berg et al. Blood Cancer Journal 2018 8: 10.1038/bcj.2017.102 Abstract | Full Text Current Treatment Algorithm Essential thrombocythemia treatment algorithm 2018 Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui Blood Cancer Journal 2018 8: 10.1038/s41408-017-0041-8 Abstract | Full Text Polycythemia vera treatment algorithm 2018 Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui Blood Cancer Journal 2018 8: 10.1038/s41408-017-0042-7 Abstract | Full Text Article SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia Patricia Johansson, Ludger Klein-Hitpass, Axel Choidas, Peter Habenberger, Bijan Mahboubi et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0036-5 Abstract | Full Text Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response Xueping Luo, Zefeng Xu, Bing Li, Tiejun Qin, Peihong Zhang et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0029-4 Abstract | Full Text Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1 Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, Mikkael A. Sekeres, Betty K. Hamilton et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0040-9 Abstract | Full Text Review Article Pathogenesis of bone disease in multiple myeloma: from bench to bedside Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou & Meletios A. Dimopoulos Blood Cancer Journal 2018 8: 10.1038/s41408-017-0037-4 Abstract | Full Text Correspondence Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers Alissa Visram, Christopher Bredeson, David Allan, Mitchell Sabloff, Lothar Huebsch et al. Blood Cancer Journal 2018 8: 10.1038/s41408-018-0050-2 Abstract | Full Text Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma Kazuna Tanba, Yoshiaki Chinen, Hitoji Uchiyama, Nobuhiko Uoshima, Kazuho Shimura et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0043-6 Abstract | Full Text Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition Gabriela Galicia-Vázquez, Sarah Smith & Raquel Aloyz Blood Cancer Journal 2018 8: 10.1038/s41408-017-0039-2 Abstract | Full Text EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental Mrinal M. Patnaik, Rangit Vallapureddy, Terra L. Lasho, Katherine P. Hoversten, Christy M. Finke et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0045-4 Abstract | Full Text Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways Mathijs Willemsen, Myrurgia Abdul Hamid, Bjorn Winkens & Axel zur Hausen Blood Cancer Journal 2018 8: 10.1038/s41408-017-0047-2 Abstract | Full Text Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia Pablo Mozas, Alfredo Rivas-Delgado, Tycho Baumann, Neus Villamor, Valentín Ortiz-Maldonado et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0044-5 Abstract | Full Text Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli & Tiziano Barbui Blood Cancer Journal 2018 8: 10.1038/s41408-017-0038-3 Abstract | Full Text Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed? Maura Nicolosi, Mythri Mudireddy, Naseema Gangat, Animesh Pardanani, Curtis A. Hanson et al. Blood Cancer Journal 2018 8: 10.1038/s41408-017-0046-3 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.